Skip to main content

MoneyWorks4Me

Mahamaya Lifesciences informs about change in management

30 Sep 2026 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III of the said Regulations, Mahamaya Lifesciences has informed that the members of the Company, based on the recommendations of Board of Directors & Nomination and Remuneration Committee approved the following resolutions at their meeting held on Tuesday, September 29, 2026, at 11:00 AM: Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Gopal Krishna Raju as Independent Director, Re-designation of Krishnamurthy Ganesan as Chairman, and Re-designation of Prashant Krishnamurthy as Managing Director.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
UPL 566.40
PI Industries 1615.00
Bayer CropScience 3345.60
Sharda Cropchem 660.80
Sumitomo Chem. India 341.65
View more..